Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$21.54 - $24.41 $86 - $97
4 Added 0.34%
1,179 $26,000
Q2 2023

Aug 01, 2023

BUY
$12.62 - $24.47 $9,856 - $19,111
781 Added 198.22%
1,175 $28,000
Q1 2023

Apr 28, 2023

BUY
$12.98 - $17.1 $3,154 - $4,155
243 Added 160.93%
394 $5,000
Q4 2022

Jan 27, 2023

BUY
$13.92 - $17.0 $167 - $204
12 Added 8.63%
151 $2,000
Q3 2022

Nov 08, 2022

BUY
$13.36 - $16.75 $53 - $67
4 Added 2.96%
139 $2,000
Q2 2022

Aug 10, 2022

BUY
$12.69 - $19.25 $228 - $346
18 Added 15.38%
135 $2,000
Q1 2022

May 02, 2022

BUY
$15.5 - $23.89 $1,813 - $2,795
117 New
117 $2,000
Q3 2021

Oct 28, 2021

SELL
$17.38 - $21.54 $121 - $150
-7 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$18.47 - $22.11 $129 - $154
7 New
7 $0

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.